查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924761

手术机器人市场按组件、应用和最终用户划分 - 全球预测 2026-2032 年

Surgical Robotics Market by Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，手术机器人市场价值将达到 97.8 亿美元，到 2026 年将成长至 106.9 亿美元，到 2032 年将达到 185.2 亿美元，年复合成长率为 9.54%。

关键市场统计数据
基准年 2025 97.8亿美元
预计年份：2026年 106.9亿美元
预测年份 2032 185.2亿美元
复合年增长率 (%) 9.54%

在外科机器人技术正处于临床、技术和商业性转折点之际，策略性应用正在重塑其应用格局和竞争地位。

手术机器人领域正处于战略转折点，其驱动力源于器械技术进步、软体智慧以及医疗系统优先事项的融合。临床团队寻求能够减少手术差异、改善治疗效果并缩短復原时间的工具，而医院管理者则优先考虑可预测的营运经济效益、工作流程整合以及病患吞吐量的显着提升。同时，小型化、增强触觉回馈和云原生分析等技术的进步正在拓展机器人系统及其周边设备的临床应用范围。这些技术变革辅以不断发展的报销和法规结构，这些框架越来越重视基于证据的价值论证，以及一个强调总体拥有成本和全生命週期支持的服务供应商生态系统。

临床实践、平台模组化和商业服务模式的变革性变化正在重新定义手术机器人如何创造临床和经济价值。

从手术室到企业层面，外科机器人领域正经历一系列相互关联的变革。首先，临床实践正朝着特定手术流程的自动化和先进的器械操控性方向发展，扩大了机器人辅助手术能够带来显着益处的手术范围。同时，单一整体式的平台正向模组化系统和器械生态系统转变，使医院能够根据病例组合和资金限制灵活扩展手术能力。其次，软体正成为关键的差异化因素。先进的影像融合技术、人工智慧驱动的决策支援工具和手术分析技术，能够提高手术结果的可预测性，并加快外科医生资格认证流程。

关税驱动的成本压力和供应链调整如何重塑外科机器人领域的采购、製造本地化和生命週期策略

关税的征收或贸易政策调整会影响医疗设备，进而显着改变整个手术机器人生态系统的采购决策、供应链结构和定价策略。关税变动不仅直接对资本设备造成价格压力，还会间接影响手术经济效益的关键要素—器械、组件和耗材的成本。医院和门诊中心正透过推迟设备更新周期、在扩建过程中优先选择成本较低的系统，或与供应商协商更严格的服务和耗材定价来应对这些成本压力。

针对不同细分市场的洞察，将产品模组化、临床证据和客製化服务模式结合，以应对不同专科和临床环境下的不同采用模式。

細項分析揭示了不同产品类型、临床应用、终端使用者环境和组件类别的需求趋势和采用障碍。这些差异应为制定有针对性的市场进入策略提供基础。在产品层面，仪器和配件、服务以及系统各自的采用曲线各不相同。仪器和配件是耗材收入的主要来源，需要持续供应。服务包括咨询以及安装、培训、维护和支持，这些对于顺利的临床过渡至关重要。系统是资本密集核心资产，也是临床专案的基础。应用细分錶明，不同专科的临床价值提案有所不同。一般外科和妇科手术优先考虑效率和缩短住院时间，神经外科强调精准性和影像整合，整形外科专注于对位和植入放置，泌尿系统则需要微创方法来缩短恢復时间。终端使用者细分錶明，门诊手术中心、医院和专科诊所在采购和营运重点方面存在差异。门诊中心重视低准入成本和快速週转；医院重视企业整合和多学科效用；专科诊所重视针对特定手术流程的优化以及可预测的单例经济效益。组件细分突显了硬体、服务和软体之间的相互关係。硬体性能必须由服务提供支持，包括咨询、安装、培训、维护和支援。软体也越来越多地透过分析、影像处理和工作流程编排来释放价值。

区域趋势要求制定量身定制的监管、报销和本地化策略，以确保全球临床应用和计画的永续性。

手术机器人领域的区域发展趋势受各地区管理体制、报销结构和医疗服务模式差异的影响，这些差异也影响企业的扩张重点和伙伴关係策略。在美洲，医院基础设施的投资以及人们对微创手术日益增长的兴趣，推动了对能够展现手术效率和良好围手术全期效果的系统和器械的需求。尤其是在美国，完善的公立和私人医疗支付体系奖励那些能够显着提升临床疗效和手术效率的系统和器械，这促使製造商投资于上市后监测和真实世界数据收集，以支持医院的采购决策。在拉丁美洲，机器人技术的部署通常遵循分阶段的方法，由领先的都市区医院率先部署先进平台，然后发展成为区域培训中心。

平台现有企业、专业创新者和软体主导新进业者将如何透过伙伴关係和以结果为导向的服务模式携手塑造竞争地位

随着老牌医疗设备製造商、机器人专家和新兴软体主导企业的融合，外科手术机器人领域的竞争格局正在改变。拥有整合平台的市场领导受益于规模经济、成熟的实施经验以及跨多个专科的临床检验，但他们也在寻求模组化产品，以满足预算有限的买家和特定手术应用的需求。专业机器人公司通常透过特定领域的创新来脱颖而出，例如单一手术系统和高度微型化的器械，并透过与进行大量手术的领先医疗中心密切合作来加速临床应用。软体主导公司透过提供可添加到现有硬体的先进影像融合技术、术中导航和手术分析功能，重新定义了价值，从而创造了新的服务和订阅收入来源。

给经营团队的可操作建议：透过整合模组化产品开发、全面服务交付和实证商业模式来加速产品推广应用

致力于加速产品推广并巩固市场地位的领导者应优先考虑整合产品设计、服务和实证实践的整合策略。首先，产品蓝图应强调模组化架构和互通软体，从而实现增量投资并轻鬆整合到医院的IT和影像生态系统中。这种方法可以降低医院在多个医疗部门间最大化资产利用率的应用障碍。其次，建立包含咨询、实施和培训以及维护和支援在内的综合服务包，可以最大限度地减少临床摩擦，并加快首例病例的开展。有效的培训计画和认证流程可以减少结果的差异性，并培养能够推动组织更广泛应用的临床领导者。第三，投资建设能够捕捉手术结果和营运指标的数据平台对于支援与支付方的合作以及组织价值评估至关重要。真实世界的临床数据对于协商有利的采购条款以及区分临床和经济价值提案至关重要。

本研究采用严谨的混合方法调查方法，结合相关人员访谈、二手证据和情境分析，检验其对技术、服务和政策的影响。

本分析结合了第一手和第二手调查方法，以确保对外科机器人领域形成全面、多角度的观点。第一手研究包括与临床、采购和工程部门的相关人员进行结构化对话，以收集有关推广应用驱动因素、营运障碍和服务优先事项的第一手资讯。此外，还对医院管理人员、多专科外科医生以及门诊和专科诊所营运经理进行了深入访谈，以确定临床应用案例的优先顺序并验证培训需求。第二手研究则依赖监管文件、临床文献和公开讯息，以支持技术趋势和合作活动，并检验不断变化的报销框架和监管路径。

策略重点的关键整合，着重于临床证据、互通性和稳健的服务模式，以支持外科机器人领域的持续成长。

手术机器人技术正从少数基础平台主导的时代迈向一个更加多元化的生态系统，其特点是模组化硬体、智慧软体和整合提案。临床需求在各个专科领域日益多样化，医疗系统也越来越注重从临床结果和营运价值观点方面评估技术。随着关税和价值链趋势的演变，采购决策变得更加复杂，製造商正致力于在地化、弹性价格设定和建立更完善的服务网络。能够将技术优势转化为可预测的临床效益、提供扩充性的培训和维护服务，并能向医院采购委员会清楚阐述整体拥有成本的公司，才能最终获得成功。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 手术机器人市场（依组件划分）

  • 硬体
  • 服务
    • 咨询
    • 安装和培训
    • 维护和支援
  • 软体

第九章 依应用分類的手术机器人市场

  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科手术
  • 泌尿系统

第十章 以最终用户分類的手术机器人市场

  • 门诊手术中心
  • 医院
  • 专科诊所

第十一章 各地区手术机器人市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 手术机器人市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 各国手术机器人市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国手术机器人市场

第十五章：中国手术机器人市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accuray Incorporated
  • Asensus Surgical, Inc.
  • Auris Health, Inc.
  • Corindus Vascular Robotics
  • Curexo Technology Corporation
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Mazor Robotics Ltd.
  • Medrobotics Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Renishaw plc
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Think Surgical, Inc.
  • Tinavi Medical Technologies Co., Ltd.
  • TransEnterix, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7A380DA7C485

The Surgical Robotics Market was valued at USD 9.78 billion in 2025 and is projected to grow to USD 10.69 billion in 2026, with a CAGR of 9.54%, reaching USD 18.52 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.78 billion
Estimated Year [2026] USD 10.69 billion
Forecast Year [2032] USD 18.52 billion
CAGR (%) 9.54%

A strategic introduction that frames the clinical, technological, and commercial inflection points reshaping adoption and competitive positioning in surgical robotics

The surgical robotics sector stands at a strategic inflection point driven by converging advances in instrumentation, software intelligence, and health-system priorities. Clinical teams are seeking tools that reduce variability, improve outcomes, and shorten recovery, while hospital administrators prioritize predictable operational economics, workflow integration, and demonstrable improvements in patient throughput. Concurrently, engineering progress in miniaturization, enhanced haptic feedback, and cloud-native analytics is expanding the clinical envelope of robotic systems and peripherals. These technological shifts are complemented by evolving reimbursement and regulatory frameworks that are increasingly receptive to evidence-based demonstrations of value, and by an ecosystem of service providers that emphasize total-cost-of-ownership and lifecycle support.

Against this backdrop, commercial strategies are diversifying. Some manufacturers are deepening relationships with device-agnostic service providers to improve installation and training throughput, while others are integrating advanced software capabilities to capture clinical and operational data that informs continuous improvement. New entrants are focusing on niche applications and lower-cost systems to address ambulatory and specialty clinic use cases, while established players continue to push integrative platforms that bundle hardware, software, and long-term service agreements. As a result, stakeholders must balance near-term clinical adoption goals with longer-term platform and ecosystem plays that shape competitive differentiation and durable revenue streams.

Transformative shifts in clinical practice, platform modularity, and commercial service models that are redefining how surgical robotics deliver clinical and economic value

The landscape for surgical robotics is being transformed by a set of interrelated shifts that extend from the operating room to the enterprise level. First, clinical practice is moving toward procedure-specific automation and enhanced instrument dexterity, which is broadening the scope of procedures where robotic assistance can offer measurable benefits. This clinical broadening is accompanied by a shift from singular monolithic platforms to modular systems and instrument ecosystems that allow hospitals to scale capabilities according to case mix and capital constraints. Second, software is becoming a primary differentiator: advanced imaging fusion, AI-driven decision aids, and procedural analytics are enabling more predictable outcomes and more rapid credentialing pathways for surgeons.

Third, the commercial model is evolving as providers demand flexible pricing, outcome-based contracting, and managed-service offerings that mitigate upfront capital intensity. This has encouraged service-oriented business models that bundle consulting, installation and training, and maintenance and support to improve time-to-value. Fourth, regulatory pathways and payer engagement are aligning around real-world evidence and post-market surveillance, creating incentives for manufacturers to invest in longitudinal data capture and outcomes research. Finally, supply chain resilience and localization pressures are prompting manufacturers to reassess sourcing strategies and partnerships, accelerating regional manufacturing and localized support networks to improve responsiveness and reduce operational risk. Together, these shifts are creating opportunities for agile players that can synchronize product innovation with services, reimbursement strategies, and data-driven value propositions.

How tariff-induced cost pressures and supply chain adjustments are reshaping procurement, manufacturing localization, and lifecycle strategies across surgical robotics

The imposition of tariffs and trade policy adjustments affecting medical devices can materially alter procurement decisions, supply chain architectures, and pricing strategies across the surgical robotics ecosystem. Tariff changes create both immediate price pressures for capital equipment and secondary impacts on the cost of instruments, subassemblies, and consumables that are critical to procedural economics. Hospitals and ambulatory centers respond to such cost pressures by delaying capital replacement cycles, prioritizing lower-cost systems for expansion, or negotiating more rigorous service and consumable pricing with vendors.

Moreover, tariffs influence strategic sourcing: manufacturers may accelerate localization of manufacturing, shift to alternative component suppliers from tariff-exempt jurisdictions, or increase vertical integration to insulate margins. These responses require capital and operational adjustments, including requalification of suppliers and recalibration of inventory strategies to mitigate lead-time variability. In parallel, service providers and systems integrators may see increased demand for installation, retrofit, and upgrade services as buyers seek to extend the useful life of existing assets rather than pursue costly replacements.

Finally, certainty and transparency in supply chain cost structures become a competitive advantage. Companies that can articulate clear mitigation strategies, long-term service commitments, and flexible pricing models will be better positioned to retain hospital customers and specialty clinics through periods of tariff-driven cost volatility. Clear communication of total-cost-of-ownership, lifecycle support, and evidence of supply chain resilience will influence procurement committees and clinical leaders who must balance clinical performance against constrained capital budgets.

Segment-specific insights that align product modularity, clinical evidence, and tailored service models to differentiated adoption patterns across specialties and care settings

Segmentation analysis reveals differentiated demand dynamics and adoption barriers across product types, clinical applications, end-user settings, and component categories, and these distinctions should inform targeted go-to-market strategies. Within the product dimension, instruments and accessories, services, and systems each follow distinct adoption curves: instruments and accessories often drive consumable revenue and require tight supply continuity, services encompass consulting as well as installation and training and maintenance and support that are essential for a smooth clinical transition, and systems represent the capital-intensive hub around which clinical programs are built. Application segmentation indicates that clinical value propositions vary by specialty: general surgery and gynecological surgery typically prioritize efficiency and reduced length of stay; neurological surgery emphasizes precision and imaging integration; orthopedic surgery focuses on alignment and implant placement; and urological surgery seeks minimally invasive approaches that shorten recovery. End-user segmentation shows divergent procurement and operational priorities across ambulatory surgical centers, hospitals, and specialty clinics, where ambulatory centers often demand lower entry cost and rapid throughput, hospitals prioritize enterprise integration and cross-disciplinary utility, and specialty clinics seek procedure-specific optimization and predictable per-case economics. Component segmentation highlights the interplay between hardware, services, and software, where hardware performance must be supported by services that include consulting and installation and training and maintenance and support, and software increasingly unlocks value through analytics, imaging, and workflow orchestration.

Understanding these segments enables more precise messaging and product design. Commercial teams should tailor clinical evidence packages to specialty-specific outcome measures, structure service agreements that reflect the differentiated training needs of ambulatory and hospital settings, and ensure supply chain continuity for instruments that drive recurring revenue. Product development should prioritize modularity in systems to permit phased upgrades, and software roadmaps should align with hospital IT priorities to ease integration and data governance. Strategic partnerships with clinical societies, training centers, and third-party service providers can accelerate adoption within targeted segments by addressing both technical and operational barriers.

Regional dynamics that require tailored regulatory, reimbursement, and localization strategies to capture clinical adoption and long-term program sustainability worldwide

Regional dynamics in surgical robotics are shaped by distinct regulatory regimes, reimbursement structures, and healthcare delivery models, and these differences inform expansion priorities and partnership strategies. In the Americas, investment in hospital infrastructure and a growing focus on minimally invasive procedures drive demand for systems and instruments that can demonstrate procedural efficiency and favorable perioperative outcomes. The United States, in particular, has a sophisticated private and public payer environment that rewards evidence of improved clinical outcomes and procedural throughput, motivating manufacturers to invest in post-market studies and real-world data collection to support hospital procurement decisions. Latin American adoption often follows a phased approach where leading hospitals in urban centers adopt advanced platforms and subsequently become regional training hubs.

Across Europe, the Middle East & Africa, regulatory harmonization efforts coexist with country-level reimbursement variability, requiring nuanced market entry strategies. European health systems emphasize cost-effectiveness and tender-based procurement, which favors solutions that can demonstrate clear total-cost-of-ownership advantages and strong service frameworks. The Middle East and Africa regions often prioritize rapid capability buildup and may favor bundled service and training offerings to accelerate clinical adoption across nascent programs. In Asia-Pacific, heterogeneity ranges from highly advanced markets with robust innovation ecosystems and strong local manufacturing capabilities to emerging markets where affordability and distributorship models dominate. Several Asia-Pacific countries are investing in localized manufacturing and clinical training centers, creating opportunities for partnerships that blend technology transfer with local service provision. Across regions, companies that adapt pricing models, localize support, and build evidence aligned with payer expectations will accelerate uptake and long-term program sustainability.

How competitive positioning is shaped by platform incumbency, specialized innovators, and software-driven entrants collaborating through partnerships and outcome-focused service models

Competitive dynamics in the surgical robotics space are evolving as established medical device manufacturers, focused robotics specialists, and software-first entrants converge. Market leaders with integrated platforms benefit from scale, installed base, and clinical validation across multiple specialties, but they face pressure to modularize offerings to address budget-constrained buyers and procedure-specific use cases. Specialist robotics firms differentiate through domain-focused innovations, such as single-procedure systems or highly miniaturized instruments, and often accelerate clinical adoption by aligning closely with high-volume centers of excellence. Software-focused companies are redefining value by delivering advanced imaging fusion, intraoperative guidance, and procedural analytics that can be layered onto existing hardware, creating new service and subscription revenue streams.

Partnerships and alliances are a defining feature of competitive strategy, with collaboration between device makers, imaging companies, and health systems enabling tighter integration of clinical workflows. Additionally, M&A and strategic investments continue to reconfigure the competitive map as companies seek to fill capability gaps in software, navigational systems, and service delivery. For shorter time-to-value, firms that invest in robust training programs, scalable maintenance networks, and demonstrated outcomes data will be better positioned to secure long-term service agreements and recurring revenue. Moreover, companies that offer transparent procurement models, flexible financing, and outcome-aligned contracts will gain traction with hospital procurement teams focused on predictable financial performance and clinical risk mitigation.

Actionable recommendations for executives to align modular product development, comprehensive service delivery, and evidence-driven commercial models for accelerated adoption

Leaders seeking to accelerate adoption and strengthen market positions should prioritize a coordinated strategy that links product design, services, and evidence generation. First, product roadmaps should emphasize modular architectures and interoperable software that enable phased investments and easier integration into hospital IT and imaging ecosystems. This approach reduces barriers to adoption for hospitals that need to maximize asset utilization across multiple specialties. Second, establish comprehensive service bundles that include consulting, installation and training, and maintenance and support to minimize clinical friction and accelerate time-to-first-case. Effective training programs and credentialing pathways will reduce variability in outcomes and foster clinician champions who drive broader institutional adoption. Third, invest in data platforms that capture procedural outcomes and operational metrics to support payer engagement and institutional value assessments. Real-world evidence will be critical for negotiating favorable procurement terms and for differentiating the clinical and economic value proposition.

Fourth, build supply chain resilience through strategic supplier diversification, localized manufacturing where feasible, and inventory strategies that mitigate tariff and logistical risks. Fifth, pursue targeted partnerships with clinical centers of excellence, imaging providers, and healthcare systems to co-develop protocols and to accelerate clinical validation across priority applications. Finally, adopt flexible commercial models, including managed-service agreements and outcome-based pricing pilots, to align incentives with health-system goals and reduce procurement friction. Executing these recommendations requires cross-functional coordination across R&D, commercial, regulatory, and operations teams to ensure that product capabilities, service delivery, and evidence generation are mutually reinforcing.

A rigorous mixed-method research approach integrating stakeholder interviews, secondary evidence, and scenario analysis to validate technology, service, and policy implications

This analysis synthesizes primary and secondary research methods to ensure a robust, multi-dimensional perspective on the surgical robotics landscape. Primary research included structured engagements with stakeholders across clinical, procurement, and engineering functions to capture firsthand perspectives on adoption drivers, operational barriers, and service priorities. These engagements were complemented by in-depth interviews with hospital administrators, surgeons across multiple specialties, and heads of ambulatory and specialty clinic operations to validate clinical use-case prioritization and training needs. Secondary research drew on regulatory filings, clinical literature, and public disclosures to corroborate technology trends and partnership activity, and to assess evolving reimbursement frameworks and regulatory pathways.

Analytical approaches employed technology and application mapping to identify product and clinical fit, scenario analysis to model procurement and tariff sensitivities, and value-chain mapping to highlight strategic levers for supply chain resilience and service delivery. Cross-validation techniques ensured alignment between interview insights and documented evidence, reducing bias and improving the reliability of thematic conclusions. Limitations include the variability of healthcare reimbursement across jurisdictions and the evolving nature of regulatory guidance, which underscore the importance of ongoing data collection and local validation when applying these insights to specific market-entry or expansion decisions. Where appropriate, the methodology emphasizes adaptive strategies that can be tailored to local regulatory and payer contexts to ensure relevance and applicability.

Conclusive synthesis of strategic priorities emphasizing clinical evidence, interoperability, and resilient service models that underpin sustainable growth in surgical robotics

Surgical robotics is transitioning from an era dominated by a few foundational platforms to a more pluralistic ecosystem characterized by modular hardware, intelligent software, and integrated service propositions. Clinical demand is diversifying across specialties, and health systems increasingly assess technology through the twin lenses of clinical outcomes and operational value. Tariff and supply chain dynamics add complexity to procurement decisions, prompting manufacturers to pursue localization, flexible pricing, and stronger service networks. Successful players will be those that can translate technological advantage into predictable clinical benefit, deliver scalable training and maintenance, and provide transparent total-cost-of-ownership narratives that resonate with hospital procurement committees.

Looking ahead, the companies that combine targeted clinical evidence, interoperability-focused product design, and resilient service architectures will be best positioned to capture long-term value. Strategic emphasis on partnerships, localized support, and data-driven post-market surveillance will not only de-risk adoption but also create differentiated service revenue streams. In sum, surgical robotics offers compelling opportunities for innovation and improved patient care, but realizing that potential requires integrated strategies that align product capability, clinical validation, and sustainable commercial models to meet the operational realities of care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Robotics Market, by Component

  • 8.1. Hardware
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Installation & Training
    • 8.2.3. Maintenance & Support
  • 8.3. Software

9. Surgical Robotics Market, by Application

  • 9.1. General Surgery
  • 9.2. Gynecological Surgery
  • 9.3. Neurological Surgery
  • 9.4. Orthopedic Surgery
  • 9.5. Urological Surgery

10. Surgical Robotics Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Surgical Robotics Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Surgical Robotics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Surgical Robotics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Surgical Robotics Market

15. China Surgical Robotics Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Accuray Incorporated
  • 16.6. Asensus Surgical, Inc.
  • 16.7. Auris Health, Inc.
  • 16.8. Corindus Vascular Robotics
  • 16.9. Curexo Technology Corporation
  • 16.10. Globus Medical, Inc.
  • 16.11. Intuitive Surgical, Inc.
  • 16.12. Johnson & Johnson
  • 16.13. Mazor Robotics Ltd.
  • 16.14. Medrobotics Corporation
  • 16.15. Medtronic plc
  • 16.16. MicroPort Scientific Corporation
  • 16.17. Renishaw plc
  • 16.18. Siemens Healthineers AG
  • 16.19. Smith & Nephew plc
  • 16.20. Stryker Corporation
  • 16.21. Think Surgical, Inc.
  • 16.22. Tinavi Medical Technologies Co., Ltd.
  • 16.23. TransEnterix, Inc.
  • 16.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL ROBOTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. GCC SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 98. GCC SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. G7 SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. G7 SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. G7 SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. NATO SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 118. NATO SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NATO SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)